Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Agnes Szantai"'
Autor:
Revital Schick, Lucy N Mekies, Yuval Shemer, Binyamin Eisen, Tova Hallas, Ronen Ben Jehuda, Meital Ben-Ari, Agnes Szantai, Lubna Willi, Rita Shulman, Michael Gramlich, Luna Simona Pane, Ilaria My, Dov Freimark, Marta Murgia, Gianluca Santamaria, Mihaela Gherghiceanu, Michael Arad, Alessandra Moretti, Ofer Binah
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205719 (2018)
AIMS:Dilated cardiomyopathy (DCM), a myocardial disorder that can result in progressive heart failure and arrhythmias, is defined by ventricular chamber enlargement and dilatation, and systolic dysfunction. Despite extensive research, the pathologica
Externí odkaz:
https://doaj.org/article/e1a99e6238e543028fefdc138f726611
Autor:
Irina Reiter, Ofer Binah, Mihaela Gherghiceanu, Michael Arad, Yuval Shemer, Shiraz Haron-Khun, Kaomei Guan, Silke Sperling, Binyamin Eisen, Huanhuan Cui, Ronen Ben Jehuda, Agnes Szantai, Dov Freimark, Lucy N. Mekies
Publikováno v:
Heart Rhythm. 15:267-276
Background Mutations in the PRKAG2 gene encoding the γ-subunit of adenosine monophosphate kinase (AMPK) cause hypertrophic cardiomyopathy (HCM) and familial Wolff-Parkinson-White (WPW) syndrome. Patients carrying the R302Q mutation in PRKAG2 present
Autor:
Yuval Shemer, Lubna Willi, Michael Arad, Michael Gramlich, Ofer Binah, Mihaela Gherghiceanu, Alessandra Moretti, Dov Freimark, Ronen Ben Jehuda, Rita Shulman, Meital Ben-Ari, Luna Simona Pane, Binyamin Eisen, Tova Hallas, Gianluca Santamaria, Revital Schick, Agnes Szantai, Lucy N. Mekies, Ilaria My, Marta Murgia
Publikováno v:
PLoS One
PLOS ONE
PLoS ONE
PLOS ONE 13(10), e0205719 (2018). doi:10.1371/journal.pone.0205719
PLoS ONE, Vol 13, Iss 10, p e0205719 (2018)
PLOS ONE
PLoS ONE
PLOS ONE 13(10), e0205719 (2018). doi:10.1371/journal.pone.0205719
PLoS ONE, Vol 13, Iss 10, p e0205719 (2018)
Aims Dilated cardiomyopathy (DCM), a myocardial disorder that can result in progressive heart failure and arrhythmias, is defined by ventricular chamber enlargement and dilatation, and systolic dysfunction. Despite extensive research, the pathologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3123d25edbfb721332acd04884d6e3c7
https://hdl.handle.net/21.11116/0000-0002-F13F-821.11116/0000-0002-F140-521.11116/0000-0002-F13D-A
https://hdl.handle.net/21.11116/0000-0002-F13F-821.11116/0000-0002-F140-521.11116/0000-0002-F13D-A
Autor:
András Makkos, Ágnes Szántai, János Pálóczi, Judit Pipis, Bernadett Kiss, Paola Poggi, Péter Ferdinandy, Alexandros Chatgilialoglu, Anikó Görbe
Publikováno v:
Frontiers in Physiology, Vol 10 (2020)
IntroductionThe use of comorbidity models is crucial in cardioprotective drug development. Hypercholesterolemia causes endothelial and myocardial dysfunction, as well as aggravates ischemia/reperfusion (I/R)-induced myocardial injury. Endogenous card
Externí odkaz:
https://doaj.org/article/636eef7e34ba42c18c1c61b97bfa70a2
Autor:
Renáta Gáspár, Kamilla Gömöri, Bernadett Kiss, Ágnes Szántai, János Pálóczi, Zoltán V. Varga, Judit Pipis, Barnabás Váradi, Bence Ágg, Tamás Csont, Péter Ferdinandy, Monika Barteková, Anikó Görbe
Publikováno v:
Molecules, Vol 25, Iss 15, p 3426 (2020)
Search for new cardioprotective therapies is of great importance since no cardioprotective drugs are available on the market. In line with this need, several natural biomolecules have been extensively tested for their potential cardioprotective effec
Externí odkaz:
https://doaj.org/article/504202b5d6854673b8b78426b30ec286